The Institute of Beijing Rongxiang Regenerative Medicine is on the list of the High Technology Enterprise Review

 

Good news is coming with the beginning of the year of dragon. MEBO International Group has got the notice from the committee of Science and Technology of BDA (Beijing Economic-Technological Development Area) said: The Institute of Beijing Rongxiang Regenerative Medicine has been successfully reviewed as the high technology enterprises of Beijing in 2011 after apply, review and public notification. It was the first group of high technology enterprise that got the approval in Beijing.

The state issued a new approval standard of high technology enterprise since 2008 which include many strict rules and indicators such as enterprise who apply must have intellectual property rights and capability of the commercialization of research findings, must have standard research and development and organization as well as financial increase etc. The Institute of Beijing Rongxiang Regenerative Medicine depends on its abundant science and technology strength has been approved as the first group of high technology enterprise of Beijing in 2008. Three year after that, it successfully reviewed as the high technology enterprise which test the development and high tech innovation capacity of MEBO International Group. Thus it reflects the thriving and prosperous development of MEBO and confirms the hard work and achievements of staff in the past three years. The review will further encourage us to make a new record in the field of Regenerative Restoration Science and benefit more human beings.

    Being approved as the high technology enterprise is not only an honor of the company but also promotes the brand image as well as brings more profits for the company. Enterprise will benefit from the related tax preferential policy which reduces the income tax to 15% thus largely decrease the operating cost. Meanwhile, enterprise can also apply for other municipal funds to support the development of the company.

The Institute of Beijing Rongxiang Regenerative Medicine has got many achievements in the field of regenerative restoration science research with the great efforts of technical personnel. We finished a series of researches including the preliminary test of nano regenerative substance, research of in vitro cell cultivation of cell anti-senile protein, research of the mechanism of anti-senile of regenerative restoration (histology such as animal bone marrow, liver, lung, kidney, heart and vessels), research about the mechanism of cell life cycle of regenerative anti-cancer treatment (3T3 cell), research about the regenerative restoration and rejuvenation of aged gastrointestinal system, research of the regenerative restoration of chronic atrophic gastritis, research of the regenerative restoration of human kidney failure (on going), research of the regenerative restoration of chronic leukemia ( on going), standard technical process of skin regenerative restoration and rejuvenation, research of anti oxidize effects of regenerative skin care products etc.
     

With the coming year of dragon MEBO International Group also face with a year of fast development. We believe the science and financial development of MEBO International Group will come to a new high in the year of dragon.